🚀 Nano-Engine has reached its final meeting! One month ago, our Nano-Engine consortium met in Poland for the final project meeting. We want to thank our hosts, QSAR Lab, for their warm hospitality and for setting the stage for a successful final gathering. 🧬 Over the course of the project, the consortium worked on an …
💡 Where are we now in our mission of paving the way for in situ CAR-T cell engineering? Recently, the Nano-Engine consortium gathered in Stockholm for our third annual meeting, hosted by Karolinska Institutet. 🚀 Since our previous in-person meeting, we’ve made significant progress indeveloping innovative synthetic vectors for engineering CAR-T cells directlywithin the body. …
Nano-Engine consortium meeting at Karolinska Institutet Read More »
We’re excited to reveal the refreshed logo for Nano-Engine, thanks to the creative work of our newest partner, QSAR Lab! This redesign perfectly reflects our mission to revolutionize in vivo cell programming and push the boundaries of targeted gene therapy. With Nano-Engine’s Targeted Nanoparticle approach, we’re paving the way for in vivo CAR-T cell therapies …
At the end of May, all members of the Nano-Engine project gathered for the annual in-person consortium meeting hosted by SINTEF in Trondheim, Norway. During this meeting, each of the partners presented updates obtained during the first year of the project, which started on April 1st 2023, funded by the EU EIC Pathfinder (grant number …
Last month, the consortium members of the Nano-Engine project gathered in Utrecht (NL) for the kick-off meeting of this exciting project focused on targeted gene therapy. Nano-Engine started on April 1st 2023 and will run for 3 years, funded by the EU EIC Pathfinder open programme. The main goal of Nano-Engine is to demonstrate preliminary …
This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant number 101098944. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council. Neither the European Union nor the granting authority can be held responsible for them.
